Spark Therapeutics, Inc.
14 clinical trials · Sponsor
◉ Watch Spark Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of a Gene Therapy Treatment for Hemophilia A (NCT06297486) | Spark Therapeutics, Inc. | 2024-03-13 |
| A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) (NCT04093349) | Spark Therapeutics, Inc. | 2020-10-01 |
| Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease (NCT03893240) | Spark Therapeutics, Inc. | 2019-06-12 |
| Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588) | Spark Therapeutics, Inc. | 2019-01-30 |
| Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants (NCT03876301) | Spark Therapeutics, Inc. | 2019-01-21 |
| A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US (NCT03597399) | Spark Therapeutics, Inc. | 2019-01-10 |
Track Spark Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.